| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6075576 | Journal of Investigative Dermatology | 2015 | 4 Pages |
Abstract
Although several genetic diseases are caused by mutations in channels made by connexin family members, there has been little progress in the development and validation of therapeutic options. An in vitro study in this issue of JID suggests that an anti-malarial drug may be beneficial in keratitis-ichthyosis deafness, a severe conexin channel disease associated with potentially fatal recurrent infections.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Roberto Bruzzone,